Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Mechanisms of action and therapeutic application of glucagon-like peptide-1
LP3-R is a triple agonist targeting the glucagon-like peptide-1 (LP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
What started as a treatment for type 2 diabetes has rapidly evolved into a platform therapy influencing obesity, cardiovascular disease, fatty liver disease, neurodegeneration, inflammation, and potentially oncology
Many patients achieve better glucose control on the combination than on either drug alone, but this can vary between individuals
Smoking and alcohol These can deplete glutathione levels , reducing effectiveness
US$ 24.27
US$ 23.32
US$ 22.68
US$ 21.33
US$ 29.72
US$ 20.80
US$ 21.53
US$ 20.83
US$ 24.55
US$ 27.39
